Related Topics:
Facility ID: 95688LZCRP700EU
Facility Name and Address: ALZA CORP 700 EUBANKS DRIVE VACAVILLE, CA 95688 Parent Company: JOHNSON & JOHNSON INC Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Dichloromethane Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000075092
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2021 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA Approved Formula |
|
2020 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA approved process for manufacturing medication |
|
2019 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - Material is ingredient in FDA approved pharmaceutical manufacturing process |
|
2018 |
Barriers: B6-No Information B6 - Pollution prevention previously implemented - additional reduction does not appear technically or economically feas
|
Other Environmental Practices: Recycling - Due to EPA changes related to allowable use of Methylene Chloride in 2019, it is no longer economically viable to recycle the waste solution generated from this process. Therefore, estimates for recycled waste in 2019 reflect only a few months of recycling and incineration for the remaining portion of the year. Further, it is expected that all waste generated in 2020 will have to be sent for incineration. |
|
2017 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA approved manufacturing process |
|
2016 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA regulated process. |
|
2015 |
Barriers: B4-Barriers to P2 B4 - Source reduction activities were implemented but were unsuccessful.
|
Barriers to P2: B4 - Source reduction activities were implemented but were unsuccessful. - Material use dictacted by FDA approved formula for product manufacturing process. |
|
2014 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Source Reduction: General Environmental Management - Procedures for manufacturing process and waste management process minimize waste generated and reduce waste resulting from errors. Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA regulated formula for production cannot be altered. Other Environmental Practices: Recycling - Waste solution remaining after production activities have been completed is sent for offsite recycling and reuse. |
|
2013 |
Other Barriers to Source Reduction - No source reduction opportunities identified. |
||
2006 |
Source Reduction:: W52: Modified equipment, layout, or piping
|
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
|
|
2005 |
Source Reduction:: W32: Improved procedures for loading, unloading, and transfer operations
Source Reduction:: W52: Modified equipment, layout, or piping |
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s)
Methods to Identify SR Opportunities: T01: Internal pollution prevention opportunity audit(s) |
|
1994 |
Source Reduction:: W19: Other changes in operating practices
|
Methods to Identify SR Opportunities: T04: Participative team management
|
|
1993 |
Source Reduction:: W19: Other changes in operating practices
|
Methods to Identify SR Opportunities: T04: Participative team management
|
|
1992 |
Source Reduction:: W19: Other changes in operating practices
|
Methods to Identify SR Opportunities: T04: Participative team management
|